Effects of transplanted adipose derived stem cells on the expressions of α-SMA and DCN in fibroblasts of hypertrophic scar tissues in rabbit ears

To study the effects of transplanted adipose derived stem cells (ADSCs) on the expressions of α-smooth muscle actin (α-SMA) and decorin (DCN) in fibroblasts of hypertrophic scar tissues in rabbit ears. Twelve New Zealand white rabbits were selected; the normal subcutaneous adipose tissues in inguinal region were removed, ADSCs were extracted via enzyme digestion, cultured in Dulbecco's modified Eagle's medium (DMEM) and inoculated into the culture dish (3–5×104 cells/ml). After the rabbit ear hypertrophic scar model was established successfully, the fibroblasts of hypertrophic scar tissues in rabbit ears were separated and cultured using the mechanical method combined with enzyme digestion, and the ADSCs and scar fibroblasts were cultured in non-contact Transwell co-culture system for 21 days (experimental group); the corresponding scar fibroblasts were cultured in an ordinary 6-well plate without any treatment for 21 days (control group). The content of collagen I in fibroblasts was detected using the enzyme-linked immunosorbent assay (ELISA) kit, the mRNA expressions of α-SMA and DCN were detected via reverse transcription-polymerase chain reaction (RT-PCR), the protein expressions of α-SMA and DCN were detected via western blot analysis, and the expressions and distribution of α-SMA and DCN were detected via immunofluorescence assay. The results of ELISA showed that the content of collagen I in experimental group was decreased significantly (p<0.01). The results of RT-PCR and western blot analysis revealed that the mRNA and protein expression levels of α-SMA were significantly decreased (P<0.01, but those of DCN were significantly increased (p<0.01). Moreover, the results of immunofluorescence assay showed that the expression of α-SMA in experimental group was significantly decreased, while the expression of DCN was significantly increased. ADSCs can inhibit the mRNA and protein expressions of α-SMA and promote the mRNA and protein expressions of DCN in in vitro culture system, and they are expected to be used in the prevention and treatment of pathological scars.

[1]  S. Thibeault,et al.  Dose‐dependent effect of mitomycin C on human vocal fold fibroblasts , 2014, Head & neck.

[2]  Thomas A. Mustoe, MD, FACS,et al.  Update on Scar Management: Guidelines for Treating Asian Patients , 2013, Plastic and reconstructive surgery.

[3]  P. Palombo,et al.  Burn Scar Lipofilling: Immunohistochemical and Clinical Outcomes , 2013, The Journal of craniofacial surgery.

[4]  Shi-rong Li,et al.  Smac/DIABLO regulates the apoptosis of hypertrophic scar fibroblasts. , 2013, International journal of molecular medicine.

[5]  S. Thibeault,et al.  Vocal fold fibroblasts immunoregulate activated macrophage phenotype. , 2013, Cytokine.

[6]  G. Wang,et al.  Liposculpture and Fat Grafting for Aesthetic Correction of the Gluteal Concave Deformity Associated with Multiple Intragluteal Injection of Penicillin in Childhood , 2013, Aesthetic Plastic Surgery.

[7]  J. Fontdevila,et al.  Autologous Fat Grafting for Correction of Unaesthetic Scars , 2012, Annals of plastic surgery.

[8]  E. Tredget,et al.  Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. , 2011, Biomaterials.

[9]  R. Tranquillo,et al.  Initial Fiber Alignment Pattern Alters Extracellular Matrix Synthesis in Fibroblast-Populated Fibrin Gel Cruciforms and Correlates with Predicted Tension , 2011, Annals of Biomedical Engineering.

[10]  M. Krampera,et al.  Mesenchymal stem cells for clinical application , 2010, Vox sanguinis.

[11]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[12]  Wancai Yang,et al.  Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. , 2008, Carcinogenesis.

[13]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[14]  M. Marazzi,et al.  Fat Injection for Cases of Severe Burn Outcomes: A New Perspective of Scar Remodeling and Reduction , 2008, Aesthetic Plastic Surgery.

[15]  J. Park,et al.  Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. , 2007, Journal of dermatological science.

[16]  R. Tuan,et al.  Glucocorticoids Promote Chondrogenic Differentiation of Adult Human Mesenchymal Stem Cells by Enhancing Expression of Cartilage Extracellular Matrix Genes , 2006, Stem cells.

[17]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  S. Phan,et al.  Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. , 1995, The Journal of investigative dermatology.

[20]  J. McCarthy,et al.  Fetal Wound Healing: A Biochemical Study of Scarless Healing , 1990, Plastic and reconstructive surgery.

[21]  E. Deitch,et al.  Hypertrophic burn scars: analysis of variables. , 1983, The Journal of trauma.